Isentress Re-examination Study (MK-0518-115)
| Status: | Completed |
|---|---|
| Conditions: | HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 5/3/2014 |
| Start Date: | May 2011 |
| End Date: | June 2014 |
| Contact: | Toll Free Number |
| Phone: | 1-888-577-8839 |
Re-examination Study for General Drug Use to Assess the Safety and Efficacy of ISENTRESS in Usual Practice
This survey is conducted for preparing application materials for re-examination under the
Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the
clinical usefulness of Isentress through collecting the safety and efficacy information in
usual practice according to the Re-examination Regulation for New Drugs.
Pharmaceutical Affairs Laws and its Enforcement Regulation, its aim is to reconfirm the
clinical usefulness of Isentress through collecting the safety and efficacy information in
usual practice according to the Re-examination Regulation for New Drugs.
Inclusion Criteria:
- HIV-1 Infected Adults
- Treated with Isentress 400 mg tablet within local label during the enrollment period
Exclusion Criteria:
- Contraindication to Isentress according to the local label
We found this trial at
1
site
Click here to add this to my saved trials
